Charles River Laboratories Announces Second-Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Wall St steadies ahead of South Korean chip bellwether SK Hynix's debut
- Oil heads for weekly gains as Middle East supply risks persist
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- Software stocks slide as Starbucks builds AI tools to replace vendor software
Charles River Laboratories (CRL) Tops Q2 EPS by 32c, Lifts Guidance
August 5, 2020 7:07 AM EDTCharles River Laboratories (NYSE: CRL) reported Q2 EPS of $1.58, $0.32 better than the analyst estimate of $1.26. Revenue for the quarter came in at $682.6 million versus the consensus estimate of $641.63 million.
GUIDANCE:
Charles River Laboratories sees FY2020 EPS of $7.05-$7.35, versus the consensus of... More
